
Phytochem Remedies IPO Subscription Day 1
Posted by : sachet | Thu Dec 18 2025

Here, the Phytochem Remedies IPO launched on 17th December 2025. Bidding for the issue will close today, 26th December 2025. The primary aim of the Phytochem Remedies IPO is to raise ₹38.22 crores from the market. Also, the Phytochem Remedies IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Phytochem Remedies IPO subscription and details.
Phytochem Remedies IPO Details
| IPO Open Date | 18th December 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹88 to ₹93 per share |
| Lot Size | 1,200 Shares |
| Issue Type | Bookbuilding Issue |
| Listing At | BSE & SME |
| IPO Close Date | 22nd December 2025 |
| Listing Date | 26th December 2025 |
The price band for Riddhi Display Equipment’s IPO has been set at ₹98 per share, and a total of 1,84,89,584 shares are being issued. Let’s segregate the share quota fixed for different categories of investors.
| Categories | Shares Offered | Shares Percentage |
| Market Maker Shares Offered | 1,96,800 | 5.05% |
| NII (HNI) Shares Offered | 18,51,600 | 47.48% |
| Retail Shares Offered | 18,51,600 | 47.48% |
| Total Shares Offered | 39,00,000 | 100.00% |
Phytochem Remedies IPO Subscription Status
As of now, the Phytochem Remedies IPO has been subscribed to 0.02 times. Of these, 0.03 times are subscribed by retail investors, 0.02 times by non-institutional investors, and [.] times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of Phytochem Remedies’ IPO listing on 26th December 2025. Phytochem Remedies also has a positive outlook behind the fresh issue of 0.39 crore shares, which will raise around Rs 42.59 crores.
Phytochem Remedies IPO GMP Today

We know that higher subscription levels drive grey-market premiums for IPOs. Let’s explore the Phytochem Remedies IPO GMP for 18th December 2025.
The grey market premium for this IPO has surged to 0.00% or Rs 0.00 per share. It indicates that the estimated listing price per share is Rs 98.00. Numerous factors played a pivotal role in this jump in the GMP of Riddhi Display Equipment’s IPO. These include higher subscription rates, favourable market sentiment, and investors’ positive attitude towards IPOs.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 18-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 17-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 16-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 15-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 14-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 13-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
| 12-12-2025 | ₹98.00 | ₹0.00 | ₹98.00 | 0.00% |
About Phytochem Remedies Ltd.
Phytochem Remedies was established in August 2007. Phytochem Remedies Limited provides infrastructure consultancy services, including supervision and quality control, detailed project reports, techno-financial audits, and pre-bid advisory services. The company offers services for infrastructure projects, such as roads and highways, railways, buildings, and water resources. The company operates on a B2G model, primarily generating revenue from services to government departments and ministries, including MoRTH, NHIDCL, NHAI, PWDs, and Railways.
Phytochem Remedies Limited Financials
The company’s financial analysis is essential before applying for the Phytochem Remedies IPO. Look at the table to learn about Phytochem Remedies Limited’s financials.
| Year Ended | 30th Sep 2025 (in cr.) | 31st March 2025 (in cr.) | 31st March 2024 | 31st March 2023 |
| Assets | 53.68 | 44.50 | 41.85 | 37.07 |
| Revenue | 25.01 | 36.81 | 32.90 | 20.83 |
| Profit After Tax | 3.75 | 4.48 | 2.31 | 0.82 |
| EBITDA | 6.72 | 8.69 | 5.88 | 2.91 |
| Net Worth | 16.89 | 13.14 | 8.74 | 6.42 |
| Reserves and Surplus | 9.02 | 9.99 | 5.51 | 3.20 |
| Total Borrowings | 19.32 | 18.69 | 21.02 | 20.30 |
Explanation
Phytochem Remedies Limited’s revenue increased by 12% from ₹32.90 crores in March 2024 to ₹36.81 crores in March 2025. Moreover, the company’s PAT increased by 94% from ₹2.31 crores in March 2024 to ₹4.48 crores in March 2025.
Technical Indicators
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Phytochem Remedies IPO.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 17.24 |
| EPS (Earnings Per Share) | 5.68 |
| RoNW | 34.07% |
| ROCE | 25.29% |
| ROE | 34.07% |
| EBITDA Margin | 23.78% |
| Price to Book Value | 2.35 |
| Market Capitalisation | ₹115.39 Cr |
Phytochem Remedies IPO Listing Expectations
Phytochem Remedies IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 0.00% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 98.
It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ top long-term recommendation.
Phytochem Remedies IPO Dates
| IPO Open Date | 18th December 2025 |
| IPO Close Date | 22nd December 2025 |
| Allotment | 23rd December 2025 |
| Refund Date | 24th December 2025 |
| IPO Listing Date | 26th December 2025 |
Note: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Phytochem Remedies IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?

